Human Cell最新文献

筛选
英文 中文
EP300 promotes tumor stemness via epigenetic activation of CRISP3 leading to lobaplatin resistance in triple-negative breast cancer. EP300通过表观遗传学激活CRISP3促进肿瘤干性,导致三阴性乳腺癌对叶铂产生耐药性。
IF 3.4 3区 生物学
Human Cell Pub Date : 2024-09-01 Epub Date: 2024-06-16 DOI: 10.1007/s13577-024-01091-w
Yan Wang, Yi Zhang, Xiaowei Qi
{"title":"EP300 promotes tumor stemness via epigenetic activation of CRISP3 leading to lobaplatin resistance in triple-negative breast cancer.","authors":"Yan Wang, Yi Zhang, Xiaowei Qi","doi":"10.1007/s13577-024-01091-w","DOIUrl":"10.1007/s13577-024-01091-w","url":null,"abstract":"<p><p>Lobaplatin shows antitumor activity against a wide range of tumors, including triple-negative breast cancer (TNBC), and has been linked to cancer stem cell pool. Here, we investigated the molecular mechanisms behind lobaplatin resistance and stemness in vitro and in vivo. Two chemoresistance-related GEO data sets (GSE70690 and GSE103115) were included to screen out relevant genes. Cysteine-rich secretory protein 3 (CRISP3) was found to be overexpressed in lobaplatin-resistant TNBC and related to poor diagnosis. CRISP3 expression was significantly correlated with tumor stemness markers in lobaplatin-resistant cells. E1A-associated protein p300 (EP300) regulated CRISP3 expression by affecting the H3K27ac modification of the CRISP3 promoter. In addition, knocking down EP300 curbed the malignant biological behavior of lobaplatin-resistant cells, which was antagonized by CRISP3 overexpression. Collectively, our results highlight the EP300/CRISP3 axis as a key driver of lobaplatin resistance in TNBC and suggest that therapeutic targeting of this axis may be an effective strategy for enhancing platinum sensitivity in TNBC.</p>","PeriodicalId":49194,"journal":{"name":"Human Cell","volume":" ","pages":"1475-1488"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141327940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adipose-derived stem cells modified by TWIST1 silencing accelerates rat sciatic nerve repair and functional recovery. 经TWIST1沉默修饰的脂肪源性干细胞可加速大鼠坐骨神经的修复和功能恢复。
IF 3.4 3区 生物学
Human Cell Pub Date : 2024-09-01 Epub Date: 2024-06-21 DOI: 10.1007/s13577-024-01087-6
Bo Chen, Leining Wang, Xiaogui Pan, Shuai Jiang, Yihe Hu
{"title":"Adipose-derived stem cells modified by TWIST1 silencing accelerates rat sciatic nerve repair and functional recovery.","authors":"Bo Chen, Leining Wang, Xiaogui Pan, Shuai Jiang, Yihe Hu","doi":"10.1007/s13577-024-01087-6","DOIUrl":"10.1007/s13577-024-01087-6","url":null,"abstract":"<p><p>The regeneration of peripheral nerves after injury is often slow and impaired, which may be associated with weakened and denervated muscles subsequently leading to atrophy. Adipose-derived stem cells (ADSCs) are often regarded as cell-based therapeutic candidate due to their regenerative potential. The study aims to assess the therapeutic efficacy of gene-modified ADSCs on sciatic nerve injury. We lentivirally transduced ADSCs with shRNA-TWIST1 and transplanted modified cells to rats undergoing sciatic nerve transection and repair. Results showed that TWIST1 knockdown accelerated functional recovery of rats with sciatic nerve injury as faster nerve conduction velocity and higher wire hang scores obtained by rats transplanted with TWIST1-silenced ADSCs than scramble ADSCs. Although the rats experienced degenerated axons and decreased myelin sheath thickness after sciatic nerve injury 8 weeks after operation, those transplanted with TWIST1-silenced ADSCs exhibited more signs of regenerated nerve fibers surrounded by newly formed myelin sheaths than those with scramble ADSCs. The rats transplanted with TWIST1-silenced ADSCs presented increased expressions of neurotrophic factors including neurotrophin-3 (NT-3), brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and glial cell line-derived neurotrophic factor (GDNF) in the sciatic nerves than those with scramble ADSCs. These results suggest that genetically modifying TWIST1 in ADSCs could facilitate peripheral nerve repair after injury in a more efficient way than that with ADSCs alone.</p>","PeriodicalId":49194,"journal":{"name":"Human Cell","volume":" ","pages":"1394-1404"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11341607/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141437702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
KIN17 functions in DNA damage repair and chemosensitivity by modulating RAD51 in hepatocellular carcinoma. KIN17 通过调节肝癌中的 RAD51 在 DNA 损伤修复和化疗敏感性中发挥作用
IF 3.4 3区 生物学
Human Cell Pub Date : 2024-09-01 Epub Date: 2024-06-27 DOI: 10.1007/s13577-024-01096-5
Xueran Huang, Zichang Dai, Biyun Zeng, Xiangyan Xiao, Kashif Rafiq Zahid, Xiaocong Lin, Tiancai Liu, Tao Zeng
{"title":"KIN17 functions in DNA damage repair and chemosensitivity by modulating RAD51 in hepatocellular carcinoma.","authors":"Xueran Huang, Zichang Dai, Biyun Zeng, Xiangyan Xiao, Kashif Rafiq Zahid, Xiaocong Lin, Tiancai Liu, Tao Zeng","doi":"10.1007/s13577-024-01096-5","DOIUrl":"10.1007/s13577-024-01096-5","url":null,"abstract":"<p><p>The limited response of hepatocellular carcinoma (HCC) to chemotherapy drugs has always been a bottleneck in therapy. DNA damage repair is a major reason for chemoresistance. Previous studies have confirmed that KIN17 affects chemosensitivity. In this study, we examined the impact of KIN17 on chemotherapy response and DNA repair in HCC cells treated with oxaliplatin (L-OHP). We evaluated the expression and biological roles of KIN17 in HCC using bioinformatic analysis. The correlation between KIN17 and RAD51, particularly their nuclear expression levels, was evaluated using immunofluorescence, immunoblotting after nucleocytoplasmic separation in HCC cells, and immunohistochemistry of mouse xenograft tumors and human HCC tissues. The results indicated a significant increase in KIN17 expression in HCC tissues compared to normal tissues. The GSEA analysis revealed that upregulation of KIN17 was significantly associated with DNA damage repair. Knockdown of KIN17 led to increased DNA damage and reduced cellular survival after exposure to L-OHP. On the other hand, overexpression of KIN17 was linked to decreased DNA damage and improved cell survival following L-OHP treatment. Further experiments indicated that KIN17 affects the expression of RAD51, particularly in the nucleus. KIN17 plays a crucial role in influencing the sensitivity of HCC to chemotherapy by triggering the DNA repair response. Increased expression of KIN17 is associated with a poor prognosis for HCC patients, indicating that KIN17 could serve as a prognostic marker and therapeutic target for HCC.</p>","PeriodicalId":49194,"journal":{"name":"Human Cell","volume":" ","pages":"1489-1504"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141460254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extracellular signal-regulated kinase is activated in podocytes from patients with diabetic nephropathy. 糖尿病肾病患者荚膜细胞中的细胞外信号调节激酶被激活。
IF 3.4 3区 生物学
Human Cell Pub Date : 2024-09-01 Epub Date: 2024-07-25 DOI: 10.1007/s13577-024-01108-4
Aoi Yamashiro, Yasushi Satoh, Shogo Endo, Naoki Oshima
{"title":"Extracellular signal-regulated kinase is activated in podocytes from patients with diabetic nephropathy.","authors":"Aoi Yamashiro, Yasushi Satoh, Shogo Endo, Naoki Oshima","doi":"10.1007/s13577-024-01108-4","DOIUrl":"10.1007/s13577-024-01108-4","url":null,"abstract":"<p><p>In the past few decades, the global prevalence of diabetes has provided us with a warning about future chronic complications. Diabetic nephropathy (DN) is the main cause of end-stage kidney disease. Podocytes in the glomerulus play a critical role in regulating glomerular permeability, and podocyte injury is one of the main causes of DN. Extracellular signal-regulated kinase (ERK) is a member of the mitogen-activated protein kinase family that plays critical roles in intracellular signal transduction. In human patients with DN, phosphorylated ERK (pERK), the active form of ERK, is increased in the glomeruli. However, information on the expression of pERK, specifically in podocytes in DN, is limited. Meanwhile, high glucose induces ERK activation in immortalized podocyte cell lines, suggesting the involvement of podocytic ERK in DN. We performed an immunohistochemical study using Wilms' tumor-1 (WT-1) as a podocyte-specific marker to investigate whether podocytic pERK levels are increased in patients with DN. In the glomeruli of the DN group, we observed remarkable co-staining for WT-1 and pERK. In contrast, the glomeruli of the control group contained only a few pERK-positive podocytes. Statistical analyses revealed that, relative to healthy controls, patients with DN showed significantly increased pERK expression levels in cells that were positive for WT-1 (DN: 51.3 ± 13.1% vs. control: 7.3 ± 1.6%, p = 0.0158, t-test, n = 4 for each group). This suggests that ERK activation in podocytes is involved in the pathogenesis of DN.</p>","PeriodicalId":49194,"journal":{"name":"Human Cell","volume":" ","pages":"1553-1558"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141762093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison among different preclinical models derived from the same patient with a non-functional pancreatic neuroendocrine tumor. 比较来自同一无功能胰腺神经内分泌肿瘤患者的不同临床前模型。
IF 3.4 3区 生物学
Human Cell Pub Date : 2024-09-01 Epub Date: 2024-07-30 DOI: 10.1007/s13577-024-01107-5
Yan Wang, Zeng Ye, Xin Lou, Junfeng Xu, Desheng Jing, Chenjie Zhou, Yi Qin, Jie Chen, Xiaowu Xu, Xianjun Yu, Shunrong Ji
{"title":"Comparison among different preclinical models derived from the same patient with a non-functional pancreatic neuroendocrine tumor.","authors":"Yan Wang, Zeng Ye, Xin Lou, Junfeng Xu, Desheng Jing, Chenjie Zhou, Yi Qin, Jie Chen, Xiaowu Xu, Xianjun Yu, Shunrong Ji","doi":"10.1007/s13577-024-01107-5","DOIUrl":"10.1007/s13577-024-01107-5","url":null,"abstract":"<p><p>Pancreatic neuroendocrine tumors are the second most common tumors of the pancreas, and approximately half of patients are diagnosed with liver metastases. Currently, the improvement in the efficacy of relevant treatment methods is still limited. Therefore, there is an urgent need for in-depth research on the molecular biological mechanism of pancreatic neuroendocrine tumors. However, due to their relatively inert biology, preclinical models are extremely scarce. Here, the patient-derived organoid, and patient-derived xenograft were successfully constructed. These two models and the previously constructed cell line named SPNE1 all derived from the same patient with a grade 3 non-functional pancreatic neuroendocrine tumor, providing new tumor modeling platforms, and characterized using immunohistochemistry, whole-exome sequencing, and single-cell transcriptome sequencing. Combined with a tumor formation experiment in immunodeficient mice, we selected the model that most closely recapitulated the parental tumor. Overall, the patient-derived xenograft model most closely resembled human tumor tissue.</p>","PeriodicalId":49194,"journal":{"name":"Human Cell","volume":" ","pages":"1522-1534"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141793789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NR2F1 overexpression alleviates trophoblast cell dysfunction by inhibiting GDF15/MAPK axis in preeclampsia. 通过抑制 GDF15/MAPK 轴,过表达 NR2F1 可减轻子痫前期滋养层细胞的功能障碍。
IF 3.4 3区 生物学
Human Cell Pub Date : 2024-09-01 Epub Date: 2024-07-15 DOI: 10.1007/s13577-024-01095-6
Ke Zhang, Hailing Zhang, Bing Wang, Shanshan Gao, Caiping Sun, Cong Jia, Jinquan Cui
{"title":"NR2F1 overexpression alleviates trophoblast cell dysfunction by inhibiting GDF15/MAPK axis in preeclampsia.","authors":"Ke Zhang, Hailing Zhang, Bing Wang, Shanshan Gao, Caiping Sun, Cong Jia, Jinquan Cui","doi":"10.1007/s13577-024-01095-6","DOIUrl":"10.1007/s13577-024-01095-6","url":null,"abstract":"<p><p>Abnormal functions of trophoblast cells are associated with the pathogenesis of preeclampsia (PE). Nuclear receptor subfamily 2 group F member 1 (NR2F1) acts as a transcriptionally regulator in many diseases, but its role in PE remains unknown. Hypoxia/reoxygenation (H/R)-stimulated HTR-8/SVneo cells were used to mimic PE injury in vitro. NR2F1 overexpression alleviated trophoblast apoptosis, as evidenced by the decreased number of TUNEL-positive cells and the downregulation of caspase 3 and caspase 9 expression in cells. NR2F1 overexpression increased the invasion and migration ability of HTR-8/SVneo cells, accompanied by increased protein levels of matrix metalloproteinase (MMP)-2 and MMP-9. mRNA-seq was applied to explore the underlying mechanism of NR2F1, identifying growth differentiation factor 15 (GDF15) as the possible downstream effector. Dual-luciferase reporter, ChIP-qPCR, and DNA pull-down assays confirmed that NR2F1 bound to the promoter of GDF15 and transcriptionally inhibited its expression. GDF15 overexpression increased apoptosis and decreased the ability of invasion and migration in HTR-8/SVneo cells expressing NR2F1. MAPK pathway was involved in the regulation of PE. Administration of p38 inhibitor, ERK inhibitor, and JNK inhibitor reversed the effect of simultaneous overexpression NR2F1 and GDF15 on trophoblast apoptosis, invasion, and migration. Our findings demonstrated that NR2F1 overexpression inhibited trophoblast apoptosis and promoted trophoblast invasion and migration. NR2F1 might negatively regulate GDF15 expression by binding to its promoter region, which further inhibited MAPK signaling pathway in PE. Our study highlights that NR2F1 might sever as a potential target in PE.</p>","PeriodicalId":49194,"journal":{"name":"Human Cell","volume":" ","pages":"1405-1420"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141617484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishment and characterization of a novel MDM2/MYCN-co-amplified neuroblastoma cell line, NBN-SHIM, established from a late recurrent stage MS tumor. 建立新型 MDM2/MYCN 共同扩增神经母细胞瘤细胞系 NBN-SHIM 并确定其特征,该细胞系由晚期复发性 MS 肿瘤建立。
IF 3.4 3区 生物学
Human Cell Pub Date : 2024-09-01 Epub Date: 2024-07-30 DOI: 10.1007/s13577-024-01106-6
Keisuke Kato, Jun-Ichi Nagai, Hiroaki Goto, Masato Shinkai, Norihiko Kitagawa, Yasunori Toyoda, Toshiji Nishi, Hisato Kigasawa, Mio Tanaka, Kenji Kurosawa, Yumi Ito, Masayuki Haruta, Takehiko Kamijo, Ai Yoshimi, Masahiro Tsuchida, Noriyuki Nagahara, Yukichi Tanaka
{"title":"Establishment and characterization of a novel MDM2/MYCN-co-amplified neuroblastoma cell line, NBN-SHIM, established from a late recurrent stage MS tumor.","authors":"Keisuke Kato, Jun-Ichi Nagai, Hiroaki Goto, Masato Shinkai, Norihiko Kitagawa, Yasunori Toyoda, Toshiji Nishi, Hisato Kigasawa, Mio Tanaka, Kenji Kurosawa, Yumi Ito, Masayuki Haruta, Takehiko Kamijo, Ai Yoshimi, Masahiro Tsuchida, Noriyuki Nagahara, Yukichi Tanaka","doi":"10.1007/s13577-024-01106-6","DOIUrl":"10.1007/s13577-024-01106-6","url":null,"abstract":"<p><p>The biological heterogeneity of neuroblastoma underscores the need for an in vitro model of each molecularly defined subgroup to investigate tumorigenesis and develop targeted therapies. We have established a permanently growing cell line from a 12-year-old girl who developed a late recurrent stage MS, MDM2-amplified neuroblastoma arising in the liver and performed histological, molecular, cytogenetic, exome, and telomere analyses of the recurrent tumor and the cell line. On histology, the recurrent tumor was immunoreactive for TP53, CDKN1A, and MDM2. A molecular cytogenetic study of the recurrent tumor revealed the amplification of MDM2 but no amplification of MYCN. The established cell line, NBM-SHIM, showed amplification of both MDM2 and MYCN on double-minute chromosomes. A copy number evaluation based on exome data confirmed the finding for MYCN and MDM2 and further identified high ploidy on CDK4 and GLI2 loci in the recurrent tumor and the cell line. The telomere maintenance mechanism on the cell line is unusual in terms of the low expression of TERT despite MYCN amplification and alternative lengthening of telomeres suggested by positive value for C-circle assay and telomere contents quantitative assay. The cell line is unique because it was established from a MYCN-nonamplified, MDM2-amplified, late-relapsed stage MS neuroblastoma, and MYCN amplification was acquired during cell culture. Therefore, the cell line is a valuable tool for investigating neuroblastoma tumorigenesis and new molecular targeted therapies for disrupted ARF-TP53-MDM2 pathway and amplification of MDM2 and CDK4.</p>","PeriodicalId":49194,"journal":{"name":"Human Cell","volume":" ","pages":"1602-1609"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141856898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IL-32/NFκB/miR-205 loop sustains the high expression of IL-32 and enhances the motility of cervical cancer cells. IL-32/NFκB/miR-205 循环可维持 IL-32 的高表达并增强宫颈癌细胞的运动能力。
IF 3.4 3区 生物学
Human Cell Pub Date : 2024-09-01 Epub Date: 2024-06-20 DOI: 10.1007/s13577-024-01094-7
Jianbing Liu, Kai Yang, Xiaoyu Lin, Jing Xu, Xiaohua Cui, Jianqing Hao, Wei Wang, Wenhao Wang, Li Li, Min Hao
{"title":"IL-32/NFκB/miR-205 loop sustains the high expression of IL-32 and enhances the motility of cervical cancer cells.","authors":"Jianbing Liu, Kai Yang, Xiaoyu Lin, Jing Xu, Xiaohua Cui, Jianqing Hao, Wei Wang, Wenhao Wang, Li Li, Min Hao","doi":"10.1007/s13577-024-01094-7","DOIUrl":"10.1007/s13577-024-01094-7","url":null,"abstract":"<p><p>Human papillomavirus (HPV) infection is a major contributor to cervical cancer. Persistent HPV infection can trigger the expression of IL-32, yet the precise role of IL-32 in the occurrence and development of cervical cancer remains elusive. To investigate this, qRT‒PCR and western blotting were utilized to measure the mRNA and protein expression levels; bioinformatics analysis was used to screen differentially expressed miRNAs; wound healing and transwell assays were conducted to evaluate cell migration and invasion capabilities. Comparative analysis revealed significantly elevated IL-32 expression in cervical cancer tissues and cell lines compared to control groups. In SiHa and/or HeLa, overexpression of IL-32 and IL-32 exposure markedly upregulated miR-205, whereas its knockdown resulted in a substantial downregulation of miR-205. Furthermore, miR-205 also could significantly regulate the expression of IL-32 in HeLa and SiHa cells. Upregulation and downregulation of IL-32 led to a significant increase or decrease in NFκB expression, respectively. Treatment with BAY11-7082 (an NFκB inhibitor) notably decreased miR-205 expression but had no effect on IL-32 levels. qRT‒PCR and western blotting analyses demonstrated that both overexpression and underexpression of IL-32 and miR-205 significantly enhanced or reduced MMP2 and MMP9 expression in cervical cancer cells, respectively. Knockdown of IL-32 significantly inhibited the migration and invasion of HeLa and SiHa; conversely, treatment with rIL-32α and rIL-32γ notably promoted their migration and invasion. In brief, IL-32 is highly expressed via the formation of a positive regulatory loop with NFκB/miR-205, contributing to the persistence of inflammation and promoting the progression of cervical cancer.</p>","PeriodicalId":49194,"journal":{"name":"Human Cell","volume":" ","pages":"1434-1445"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141433211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vitro models of the choroid plexus and the blood-cerebrospinal fluid barrier: advances, applications, and perspectives. 脉络丛和血液-脑脊液屏障的体外模型:进展、应用和前景。
IF 3.4 3区 生物学
Human Cell Pub Date : 2024-09-01 Epub Date: 2024-08-05 DOI: 10.1007/s13577-024-01115-5
Christian Schwerk, Horst Schroten
{"title":"In vitro models of the choroid plexus and the blood-cerebrospinal fluid barrier: advances, applications, and perspectives.","authors":"Christian Schwerk, Horst Schroten","doi":"10.1007/s13577-024-01115-5","DOIUrl":"10.1007/s13577-024-01115-5","url":null,"abstract":"<p><p>The choroid plexus (CP), a highly vascularized endothelial-epithelial convolute, is placed in the ventricular system of the brain and produces a large part of the cerebrospinal fluid (CSF). Additionally, the CP is the location of a blood-CSF barrier (BCSFB) that separates the CSF from the blood stream in the CP endothelium. In vitro models of the CP and the BCSFB are of high importance to investigate the biological functions of the CP and the BCSFB. Since the CP is involved in several serious diseases, these in vitro models promise help in researching the processes contributing to the diseases and during the development of treatment options. In this review, we provide an overview on the available models and the advances that have been made toward more sophisticated and \"in vivo near\" systems as organoids and microfluidic lab-on-a-chip approaches. We go into the applications and research objectives for which the various modeling systems can be used and discuss the possible future prospects and perspectives.</p>","PeriodicalId":49194,"journal":{"name":"Human Cell","volume":" ","pages":"1235-1242"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11341628/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunomodulatory signalling networks in glioblastoma multiforme: a comprehensive review of therapeutic approaches. 多形性胶质母细胞瘤的免疫调节信号网络:治疗方法综述。
IF 3.4 3区 生物学
Human Cell Pub Date : 2024-09-01 Epub Date: 2024-07-31 DOI: 10.1007/s13577-024-01112-8
Souhrid Sarkar, Somi Patranabis
{"title":"Immunomodulatory signalling networks in glioblastoma multiforme: a comprehensive review of therapeutic approaches.","authors":"Souhrid Sarkar, Somi Patranabis","doi":"10.1007/s13577-024-01112-8","DOIUrl":"10.1007/s13577-024-01112-8","url":null,"abstract":"<p><p>Glioblastoma multiforme is a very aggressive type of cancer with high mortality and poor prognosis worldwide. Advanced treatment options with an understanding of the molecules and signalling mechanisms involved in this type of cancer have the potential to increase targeted therapy and decrease off-target effects, resistance, and recurrence. Glioblastoma multiforme (GBM) presents a complex tumour microenvironment with numerous cellular components and an extracellular matrix comprising multiple components. A deeper understanding of these components and corresponding signalling pathways can increase the success of immune checkpoint inhibitors in the treatment of GBM. The discovery of specific molecular changes and biomarkers has led to the investigation of tailored treatments for individual patients. Combination therapies targeting multiple pathways or utilizing different modalities are emerging as a promising strategy albeit with challenges in drug delivery to the brain. The review presents a comprehensive update of the various immunomodulatory signalling networks in GBM and highlights the corresponding therapeutic approaches by targeting them.</p>","PeriodicalId":49194,"journal":{"name":"Human Cell","volume":" ","pages":"1355-1377"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141861370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信